Fast Locator 2011-2012: Lonza - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2011-2012: Lonza



A HISTORY OF INNOVATION
In 1897, Lonza was founded on the banks of the river Lonza in the Swiss Alps by adventurous entrepreneurs. Today, Lonza continues to embody that pioneering spirit as a leading innovator and partner for the pharmaceutical, healthcare, nutrition, personal care, cosmetic, industrial biotech and life science industries.

PROVEN TRACK RECORD
For over 25 years, Lonza Custom Manufacturing has been helping emerging and large biotechnology and pharmaceutical companies improve and advance their products. Whether for clinical or commercial supply, Lonza’s complete set of development services, industry-leading manufacturing processes, and broad chemical and biotechnology platforms enable your products to reach their full potential.

EXTENSIVE CAPABILITIES & EXPERIENCE
Active pharmaceutical ingredients (APIs), highly potent APIs, advanced intermediates, fine chemicals, nutraceuticals, cosmeceuticals, antibody drug conjugates, peptides, vaccines, plasmid DNA, recombinant novel proteins, monoclonal antibodies, antibody fragments, cell-based therapeutics, research products and media services … Lonza has the know-how and experience to handle almost any pharmaceutical or biotechnology challenge, around the globe.


COMPLETE PROCESS R&D SERVICES:

  • AggreSolve Protein Aggregation Predictor
  • The GS Gene Expression System
  • XS Microbial Expression Technologies
  • Cell line construction
  • Strain design
  • Bio/catalyst design
  • Process development
  • Process scale-up
  • Process validation
  • Process transfer
  • Technology development
  • Regulatory support

WORLDWIDE, STATE-OF-THE-ART FACILITIES
North America: Portsmouth, NH; Hopkinton, MA; Walkersville, MD
Europe: Slough, UK; Kourim, CZ; Porrino, ES; Braine, BE; Verviers, BE
Asia: Nansha, CN; Singapore, SG


Contact:

Lonza
Muenchensteinerstr. 38
CH-4002 Basel
Switzerland
+41 61 316 8111
contact@lonza.com

Website:

www.lonza.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here